Quick Answer
Xylem Inc. reported Cash and Equivalents of $1.48 billion for fiscal year 2025.
Xylem Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.48B | +31.9% |
| 2024 | $1.12B | +10.0% |
| 2023 | $1.02B | +7.9% |
| 2022 | $944.00M | -30.0% |
| 2021 | $1.35B | -28.1% |
| 2020 | $1.88B | +159.0% |
| 2019 | $724.00M | +144.6% |
| 2018 | $296.00M | -28.5% |
| 2017 | $414.00M | +34.4% |
| 2016 | $308.00M | -54.7% |
| 2015 | $680.00M | +2.6% |
| 2014 | $663.00M | +24.4% |
| 2013 | $533.00M | +5.8% |
| 2012 | $504.00M | +58.5% |
| 2011 | $318.00M | +142.7% |
| 2010 | $131.00M | +0.0% |
| 2009 | $131.00M | +61.7% |
| 2008 | $81.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.19B | +20.4% | +1.8% |
| June 30, 2025 | $1.17B | +43.6% | +10.5% |
| March 31, 2025 | $1.06B | +11.8% | -5.5% |
| December 31, 2024 | $1.12B | +10.0% | +13.3% |
| September 30, 2024 | $989.00M | +40.3% | +21.3% |
| June 30, 2024 | $815.00M | +15.1% | -13.9% |
| March 31, 2024 | $947.00M | +13.1% | -7.1% |
| December 31, 2023 | $1.02B | +7.9% | +44.5% |
- Xylem Inc. showed an increase of +31.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Xylem Inc.’s cash and equivalents has grown by 1725.9% (from $81.00 million to $1.48 billion).
- The most recent figure is from Xylem Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: